Altair Nanotechnologies Receives 90-Day Extension from NASDAQ
June 05, 2003 09:00 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., June 5, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has received a letter from the NASDAQ Stock Market noting that the company meets the initial...
Altair Nanotechnologies Receives Positive RenaZorb Animal Test Results; RenaZorb, A Nanotechnology-Based Drug Candidate For Phosphate Control in Kidney Dialysis Patients, Shows Phosphate Binding In Dogs And 5/6 Nephrectomized Rats
June 03, 2003 09:00 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., June 3, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has negotiated an agreement allowing the disclosure of new animal testing data to...
Altair Nanotechnologies Completes $1.3 Million Private Placement; Company Expects 90-Day Extension on NASDAQ SmallCap Market
May 28, 2003 10:00 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., May 28, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has completed a $1.3 million private placement. Under the terms of the governing...
Altair Nanotechnologies Targets Government Grant Programs For Development Revenue
May 20, 2003 10:00 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., May 20, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) said today that the company is aggressively seeking revenues from government grant programs to support several of...
Altair Nanotechnologies President Interviewed by Chemical Market Reporter; Altair Pigment Process Continues to Generate International and Domestic Interest
May 13, 2003 14:32 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., May 13, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that an interview with the company's Present, Dr. Rudi E. Moerck, has been published in the April...
Altair Nanotechnologies Reports Passage of Science Committee Legislation by U.S. House of Representatives
May 09, 2003 10:31 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., May 9, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) reported today that the U. S. House of Representatives passed the Science Committee legislation which authorizes a...
Altair Nanotechnologies' President Provides Shareholder Update; Altair Receives Patent Number For Third Patent Pertaining To Its Hydrochloride Pigment Process
April 29, 2003 11:48 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., April 29, 2003 (PRIMEZONE) -- Altair Nanotechnologies Inc. (Nasdaq:ALTI) announced today that it has received the patent number for its third in a series of patents pertaining to Altair's...
Nevada Senator Harry Reid Tours Altair Nanotechnologies' Corporate Headquarters and Manufacturing Facility
April 17, 2003 09:41 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., April 17, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that Nevada Senator Harry Reid met with Altair management and representatives from Western...
Altair Nanotechnologies, Inc. Retains RBC Capital Markets as its Financial Advisor
April 11, 2003 10:30 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., April 11, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) announced today that it has retained RBC Capital Markets as its exclusive financial advisor to assist the company...
Altair Nanotechnologies, Inc. Reports Positive Results from In Vivo Testing of RenaZorb
April 11, 2003 09:00 ET
|
Altair Nanotechnologies Inc.
RENO, Nev., April 11, 2003 (PRIMEZONE) -- Altair Nanotechnologies, Inc. (Nasdaq:ALTI) reported today that data from laboratory testing and animal testing of RenaZorb(tm), the company's new drug...